ArticleBMC cancer2022

IMNI PRECISION trial protocol: a phase II, open-label, non-inferior randomized controlled trial of tailoring omission of internal mammary node irradiation for early-stage breast cancer.

Wei-Xiang Qi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.